Oxford Biomedica plc
OXB.L$1.10B
Small CapLSEGene Therapy🇺🇸North America900 employees
Drugs in Pipeline
4
Phase 3 Programs
1
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
OXB.L News
Catalyst Timeline
0 upcoming, 0 past
No catalysts found.
Drug Pipeline
Trovax
Clear Cell Renal Carcinoma
ProSavin
Parkinson's Disease
Interleukin-2
Carcinoma, Renal Cell
IL-2
Carcinoma, Renal Cell
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Trovax | Phase 3 | Clear Cell Renal Carcinoma | - | - |
ProSavin | Phase 2 | Parkinson's Disease | - | - |
Interleukin-2 | Phase 2 | Carcinoma, Renal Cell | - | - |
IL-2 | Phase 2 | Carcinoma, Renal Cell | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply